相关实验视频

Updated: Jun 18, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

通过CXCL6-CXCR2轴介导的PD-L2杆细胞积累塑造了骨髓瘤中免疫抑制微环境

Chengguang Wang¹, Zhenbin Lei², Chuanzhi Zhang³

¹Department of Orthopedics, People's Hospital of Chongqing Hechuan, Chongqing, People's Republic of China.

|July 31, 2024

概括

巨细胞通过CXCL6-CXCR2轴积聚在骨髓瘤 (OS),表达PD-L2抑制CD8+T细胞. 这突显了骨癌中免疫耐受性的新机制.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

骨髓瘤 (OS) 是一种具有高转移潜力的原发性骨癌.
在OS瘤微环境中的免疫细胞显著影响疾病的进展.
乳腺细胞,关键的先天性免疫细胞,在OS中了解的角色和积累机制很少.

研究的目的:

调查OS中巨细胞积累机制.
在OS瘤微环境中表征巨细胞表型.
阐明巨细胞对OS的抗瘤免疫力的功能影响.

主要方法:

在OS和相邻的非瘤组织中对瘤细胞透的分析.
评估巨细胞表型,包括PD-L2表达.
在体外研究中,使用OS组织培养超级生物来模仿瘤微环境.
涉及G-CSF,STAT3和CD8+T细胞测试的机制研究.
阻断试验以瘤细胞的PD-L2为目标.

主要成果:

骨中巨细胞的积累是由CXCL6-CXCR2轴调节的.
瘤透性巨细胞表现出高PD-L2表达,与患者预后更差相关.
来自瘤细胞的G-CSF通过STAT3激活诱导巨细胞的PD-L2表达.
表达PD-L2的巨细胞抑制CD8+T细胞的增殖和细胞因子的分泌.

结论:

乳腺细胞有助于免疫抑制和瘤进展在骨髓瘤.
CXCL6-CXCR2轴和G-CSF/STAT3通路是OS中瘤细胞PD-L2表达的关键调节者.
向巨细胞PD-L2代表了一种潜在的治疗策略,以增强骨髓瘤中抗瘤免疫力.

关键词:

这是一种免疫抑制药物.巨细胞是巨细胞.骨质肉瘤骨质肉瘤是什么在PD-L2中使用.

更多相关视频

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...